PHS FORESIGHT

Personal Health Systems Foresight

 Coordinatore AIT Austrian Institute of Technology GmbH 

 Organization address address: Donau-City-Strasse 1
city: WIEN
postcode: 1220

contact info
Titolo: Dr.
Nome: Susanne
Cognome: Giesecke
Email: send email
Telefono: 43505504564
Fax: 43505504599

 Nazionalità Coordinatore Austria [AT]
 Sito del progetto http://www.phsforesight.eu
 Totale costo 525˙458 €
 EC contributo 485˙339 €
 Programma FP7-HEALTH
Specific Programme "Cooperation": Health
 Code Call FP7-HEALTH-2012-INNOVATION-1
 Funding Scheme CSA-SA
 Anno di inizio 2012
 Periodo (anno-mese-giorno) 2012-09-01   -   2014-08-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    AIT Austrian Institute of Technology GmbH

 Organization address address: Donau-City-Strasse 1
city: WIEN
postcode: 1220

contact info
Titolo: Dr.
Nome: Susanne
Cognome: Giesecke
Email: send email
Telefono: 43505504564
Fax: 43505504599

AT (WIEN) coordinator 149˙130.00
2    THE UNIVERSITY OF MANCHESTER

 Organization address address: OXFORD ROAD
city: MANCHESTER
postcode: M13 9PL

contact info
Titolo: Ms.
Nome: Liz
Cognome: Fay
Email: send email
Telefono: 441613000000

UK (MANCHESTER) participant 169˙935.00
3    IMPETU SOLUTIONS WORLDWIDE SL

 Organization address city: MADRID
postcode: 28014

contact info
Titolo: Dr.
Nome: Totti
Cognome: Könnölä
Email: send email
Telefono: +34 658 321 050
Fax: 34914547001

ES (MADRID) participant 166˙274.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

personal    workshops    online    health    phss    joint    explored    stakeholders    policy    services    eip    deeper    phs    examined    innovation    communities    healthy    visions    strategic    personalised    actions    mismatches    community    plan    continuous    quality    aging    engagement    action    prospects   

 Obiettivo del progetto (Objective)

'This support action will coordinate strategic stakeholder engagements in the realm of Personal Health Systems (PHS) within and beyond European Union up to 2030. PHS assist in the provision of continuous, quality controlled and personalised health services to empowered individuals regardless of location. PHS are not limited to dealing with aging and eldercare, though PHS communities contribute to the European Innovation Partnership (EIP) on Active and Healthy Aging. PHS provides a horizontal development area across variety of patients, clinical specialties, technology fields and health services. Hence, the development of PHS requires and can mobilize the emergence of novel cross-disciplinary and -sectoral innovation partnerships.

With this proposal we want to achieve a deeper understanding of mismatches between the potential of PHS and current policy and innovation initiatives and framework conditions; to support more mobilized and networked innovation communities, promoting PHS around jointly formulated issues which support pooling resources and streamlining diverse innovation initiatives; to tackle future opportunities and alternative trajectories, aligning actor perspectives for the development of a joint strategic action plan, including recommendations for a possible new EIP; and finally, to achieve a transparent, open and inclusive engagement of stakeholders, and targeted dissemination of results in society.

Sufficient expertise will be provided by the consortium, the stakeholders involved, and by the scientific advisory board.'

Introduzione (Teaser)

An EU-funded study examined the landscape of personalised health systems (PHSs) to critique the current system and outline means for improvement. It also explored the future of PHSs and fostered networking and coordination among stakeholders.

Descrizione progetto (Article)

PHSs are an innovation designed to provide continuous, quality-controlled personalised health services. The http://www.phsforesight.eu/ (PHS FORESIGHT) (Personal health systems foresight) project explored PHS research, innovation and policy areas to attain a deeper understanding of the mismatches between the potential of and need for PHSs.

For the purposes of this project, PHSs were defined as wearable or in-body devices that monitor and communicate physiological and health data; intelligent processing that combines biomedical and environmental information; and actions based on information acquired from PHSs.

The project considered sources and initiatives of PHS research in Europe and identified issues that may drive or hinder its development. Researchers provided an overview of the contributions of the newly established PHS FORESIGHT online community. This includes joint preparation and evaluation of visions on PHS futures and exploration of visions and prospects to produce breakthrough innovations.

Project partners carried out community engagement and created synergies through various workshops, seminars and conferences. They also set up an interactive platform to launch a structured and systematic online consultation process.

Two workshops were held on scenarios for PHS development. They examined ways PHSs can be used in different health situations. A success scenario was also developed that examines future prospects for the development and function of PHSs in Europe over the next two decades.

Lastly, the team delivered a strategic plan for Europe. It identifies critical issues that may guide or impede PHS development and integration into public health care systems, and maps current initiatives that impact PHSs. The report also proposes strategies and actions for establishing priorities and a basis for further cooperation.

PHS FORESIGHT helped to capitalise on the potential of PHSs by clarifying joint visions for health system changes and formulating action plans to achieve them. This will ultimately lead to patient empowerment and more healthy lifestyles.

Altri progetti dello stesso programma (FP7-HEALTH)

EURHYTHDIA (2011)

Chronotherapeutic lifestyle intervention for diabetes and obesity to reset the circadian rhythm and improve cardiometabolic risk in the European working population

Read More  

HECATOS (2013)

Hepatic and Cardiac Toxicity Systems modelling

Read More  

RAPSODI (2009)

"PRe-clinicAl studies of a PSA-based human vaccine candidate targeting visceral, cutaneOus and mucocutaneous Leishmaniasis and Development of the associated procedures for further clinical trials"

Read More